Technical Analysis for ORMP - Oramed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 2.95 2.08% 0.06
ORMP closed up 2.08 percent on Friday, May 24, 2019, on 37 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ORMP trend table...

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 2.08%
Wide Bands Range Expansion 2.08%
Oversold Stochastic Weakness 2.08%
New Downtrend Bearish -0.67%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.67%
Inside Day Range Contraction -0.67%

Older signals for ORMP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Oramed Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides. The company's products primarily comprise ORMD0801, an oral insulin capsule that is in Phase II clinical trials for the treatment of diabetes; and ORMD0901, an analog for GLP-1 gastrointestinal hormone that is in per-clinical trials. Its portfolio of product candidates is based on intellectual property that allows for the protection of proteins and polypeptides in the stomach, and for their absorption through the gastrointestinal wall. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Jerusalem, Israel.
Medicine Chemistry Pharmaceutical Pharmaceutical Industry Diabetes Medication Pharmaceutical Industry In China Endocrine System Dosage Forms Insulin Peptide Hormones Treatment Of Diabetes Glucagon Like Peptide 1 Tablet Pharmaceutical Solutions
Is ORMP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 8.59
52 Week Low 2.78
Average Volume 88,308
200-Day Moving Average 3.9161
50-Day Moving Average 3.563
20-Day Moving Average 3.325
10-Day Moving Average 3.089
Average True Range 0.1799
ADX 29.01
+DI 7.8882
-DI 23.0369
Chandelier Exit (Long, 3 ATRs ) 3.4603
Chandelier Exit (Short, 3 ATRs ) 3.3697
Upper Bollinger Band 3.8591
Lower Bollinger Band 2.7909
Percent B (%b) 0.15
BandWidth 32.126316
MACD Line -0.1994
MACD Signal Line -0.1567
MACD Histogram -0.0428
Fundamentals Value
Market Cap 39.29 Million
Num Shares 13.3 Million
EPS -0.95
Price-to-Earnings (P/E) Ratio -3.11
Price-to-Sales 59.88
Price-to-Book 6.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.20
Resistance 3 (R3) 3.19 3.09 3.16
Resistance 2 (R2) 3.09 3.03 3.10 3.14
Resistance 1 (R1) 3.02 2.99 3.06 3.03 3.13
Pivot Point 2.93 2.93 2.95 2.93 2.93
Support 1 (S1) 2.86 2.86 2.89 2.87 2.77
Support 2 (S2) 2.76 2.82 2.77 2.76
Support 3 (S3) 2.69 2.76 2.74
Support 4 (S4) 2.70